Akili, Inc. (AKLI) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 41 transactions totaling $6.3K, demonstrating a bearish sentiment with -$6.3K in net insider flow. The most recent transaction on Jul 2, 2024 involved a transaction of 10,336,425 shares valued at $0.
No significant insider buying has been recorded for AKLI in the recent period.
No significant insider selling has been recorded for AKLI in the recent period.
Based on recent SEC filings, insider sentiment for AKLI is bearish with an Insider Alignment Score of 0/100 and a net flow of -$6.3K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Akili, Inc. (AKLI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading AKLI stock, having executed 41 transactions in the past 90 days. The most active insider is Chamath Palihapitiya (Executive), who has made 7 transactions totaling $100.0M.
Get notified when executives and directors at AKLI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | Sciences Private Ltd Temasek Life | Executive | Tender | 10,336,425 | $N/A | $0 | |
| Jul 2, 2024 | Palihapitiya Chamath | Executive | Tender | 8,100,000 | $N/A | $0 | |
| Jul 2, 2024 | Palihapitiya Chamath | Executive | Tender | 3,773,000 | $N/A | $0 | |
| Jul 2, 2024 | Palihapitiya Chamath | Executive | Tender | 1,900,000 | $N/A | $0 | |
| Jul 2, 2024 | Llc Puretech Health | Executive | Tender | 12,527,477 | $N/A | $0 | |
| Jun 7, 2024 | Studer Jacqueline | Executive | Payment | 5,118 | $0.42 | $2.1K | |
| May 2, 2024 | Edward Martucci Walter II | Executive | Payment | 5,174 | $0.41 | $2.1K | |
| May 2, 2024 | Studer Jacqueline | Executive | Payment | 1,840 | $0.41 | $754 | |
| Mar 10, 2024 | Franklin Matthew | Executive | Payment | 1,615 | $0.34 | $549 | |
| Mar 10, 2024 | Edward Martucci Walter II | Executive | Payment | 2,599 | $0.34 | $884 | |
| Mar 10, 2024 | Studer Jacqueline | Executive | Payment | 1,032 | $0.34 | $351 | |
| Dec 7, 2023 | Shanbhag Santosh | Executive | Award | 69,750 | $N/A | $0 | |
| Dec 7, 2023 | Studer Jacqueline | Executive | Award | 69,750 | $N/A | $0 | |
| Nov 2, 2023 | Edward Martucci Walter II | Executive | Payment | 5,337 | $0.39 | $2.1K | |
| Nov 2, 2023 | Studer Jacqueline | Executive | Payment | 1,840 | $0.39 | $718 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 15 | $100.0M | 100.0% |
Payment(F) | 12 | $18.9K | 0.0% |
Sale(S) | 4 | $6.3K | 0.0% |
Tender(U) | 5 | $0 | 0.0% |
Disposition(D) | 1 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Exercise(M) | 2 | $0 | 0.0% |
Insider selling pressure at Akili, Inc. has increased, with 8 insiders executing 41 transactions across all time. Total sales of $6.3K significantly outpace purchases of $0, resulting in a net outflow of $6.3K. This selling activity appears largely discretionary, which may warrant closer attention from investors.